CLINICAL_TRIALS
research
· 2026-04-03
Clinical Trial Update: FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer [Phase 2, Phase 3]
Summary
A phase 2/3 clinical trial is evaluating fecal microbiota transplant in combination with standard first-line therapy for initially unresectable colorectal cance…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Shanghai 10th People's Hospital | Conditions: Unresectable Colorectal Cancer, Colorectal Cancer (Locally Advanced or Metastatic) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING